Navigation Links
GeoVax Labs' First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
Date:12/13/2011

ATLANTA, Dec. 13, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm ("the Company") developing vaccines that prevent and fight Human Immunodeficiency Virus (HIV) infections, announced that the first patient has been inoculated in the Phase 1/2 clinical trial for the Company's HIV/AIDS therapeutic vaccine.  This is the first study using GeoVax Labs' vaccines for the treatment of persons who are HIV infected.

The protocol for the Phase 1/2 clinical trial will carefully monitor safety while evaluating the ability of the vaccine to elicit protective immune responses in vaccinated participants.  The trial is based on the achievement of post-vaccine viral control in animal studies conducted in recently infected non-human primates at the Yerkes National Primate Research Center, affiliated with Emory University.

Robert McNally, Ph.D., President and CEO of GeoVax Labs, stated, "Dosing the first study participant marks a major milestone for our Phase 1/2 clinical trial. We are pleased to have the AIDS Research Consortium of Atlanta, the Alabama Vaccine Research Center at the University of Alabama, Birmingham, and the AIDS Research Alliance of Los Angeles participating in the trial.  These three trial sites are actively seeking persons who are interested in and fit the criteria for the study."

To be eligible for the study, persons should have started drugs within 18 months of their last HIV negative test.  Persons who have been infected within the past 18 months, but not started drugs, are also eligible for recruitment into the study.  The first participant was enrolled at the AIDS Research Consortium of Atlanta.

About GeoVax Labs, Inc.

GeoVax is a biotechnology company developing human vaccines for diseases caused by HIV. Our goals include developing HIV/AIDS vaccines for global markets, overseeing the manufacture and testing of these vaccines u
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GeoVax Phase 2a Clinical Trial Completes Enrollment
2. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
3. GeoVax Labs, Inc. Announces Second Quarter Financial Results
4. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
5. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
6. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
7. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
8. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
9. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
10. GeoVax Labs Engages The Investor Relations Group
11. GeoVax Labs, Inc. Reports Fourth Quarter and Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015 Richmond Pharmacology ... unit with a worldwide reputation for excellence in ... publications in peer reviewed medical journals. Its officers ... regulators in discussions about rules for transparency and ... (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research is ...
(Date:5/21/2015)... Research and Markets ... of the "North American Joint Reconstruction ... Elbow Replacement, Hip Replacement, Knee Replacement, Shoulder ... to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... at $4,470.9 million in 2014 and is ...
(Date:5/21/2015)... , May 21, 2015 ... announced the addition of the "Market Assessment ... Europe" report to their offering. ,     (Logo: ... of the respiratory imaging diagnostics market in ... Europe . The service provides detailed ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... Jan. 27, 2011 CareCentrix, Inc ., the ... will present tomorrow at the World Congress, 2nd Annual ... William Kerr, Chief Medical Officer, will discuss CareCentrix,s HomeSTAR™ ... of home based interventions. Hospital readmissions ...
... Inc., a global medical technology company focused on improving blood ... 16 inspiring individuals inducted into the company,s 2010 Donation Hall ... decade, Fenwal has partnered with blood centers to recognize people ... medicine,s most vital natural resource -- blood -- is available ...
Cached Medicine Technology:CareCentrix to Present at Hospital Readmissions Conference 22010 Inductees to the Fenwal Blood Donation Hall of Fame 22010 Inductees to the Fenwal Blood Donation Hall of Fame 3
(Date:5/25/2015)... A recent report for Mass Live made ... a direct result of an opiate overdose in the state ... overdose deaths attributed to prescription opiate medications, and heroin. Mass ... geography. This issue doesn’t care about race. This issue doesn’t ... the state of Mass. reels from the effects of the ...
(Date:5/25/2015)... CA (PRWEB) May 25, 2015 Join Fiona's ... a free two-hour instructional clinic. Irish National Player, Fiona ... and give them a taste of her coaching style. Fiona ... and Novato. Camps in Novato are at Lynwood Elmentary School ... , Novato High School - June 6th, 2015 - 1:00-3:00pm. ...
(Date:5/25/2015)... TX (PRWEB) May 25, 2015 Decora Preset ... company ‘Leviton’ is now available on ‘The Hardware City.’ The ... user has to set a time and the related electronic ... When contacted a representative of the company said, “We are ... Hardware City.’ Now customers can buy Countdown Timer Switch in ...
(Date:5/24/2015)... May 24, 2015 For people who ... Chinese Enterokinase Industry, 2009-2019 Market Research Report would be ... an exhaustive study on the present market scenario of ... into the growing Chinese market of this industry. The ... overall status of the manufacturers in this industry. The ...
(Date:5/24/2015)... York (PRWEB) May 24, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled its next ... of the multidistrict litigation. According to court documents ... of Illinois, the Conference will be convened on ... Testosterone Replacement Therapy Product Liability Litigation - MDL ...
Breaking Medicine News(10 mins):Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3
... Patient Educational Program Urges Americans to ,Fight Against Heart ... ... Many U.S. adults are confused about,what heart failure is, cannot ... is a manageable condition, according,to a new survey conducted by Harris ...
... becomes newest reseller ... wireless microphone, MAYNARD, Mass., Feb. 12 ... enhancing collaboration, today announced,that the Dictaphone Healthcare Solutions ... Wireless Microphone alongside its Dragon(R),NaturallySpeaking(R) Medical speech recognition ...
... Video Blogs on,DeterminedToQuit.com, HARRISBURG, Pa., Feb. 12 ... to quit using tobacco are,now being featured on ... site, http://www.DeterminedToQuit.com ., Angela and Justin ... than a,year and are determined to quit smoking ...
... Organizations Support Wyeth Campaign to Eliminate Compounded ... International,Academy of Compounding Pharmacists (IACP) today called ... and the North American,Menopause Society (NAMS) to ... dispensing advice to patients and practitioners that ...
... Findings suggest some individuals or families may have underlying ... -- People with a personal or family history of ... rare type of dementia that causes them to lose ... report. , The condition, known as primary progressive ...
... PLANO, Texas, Feb. 12 With the recent announcement ... is an ongoing,safety review of Botox Cosmetic (botulinum toxin ... lines between the brows. Botox(R),Cosmetic received FDA approval in ... lines between the brows in people 18 to 65 ...
Cached Medicine News:Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 2Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 3Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 4Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 5Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 6Health News:Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance 2Health News:Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance 3Health News:American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals 2Health News:Learning Disabilities May Presage Later Language Problems 2Health News:Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles 2
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Products are constructed of a ... MEROCEL polyvinyl acetal sponge. Each ... beneficial to both surgeon and ... yet firm enough to gently ...
... KeraCel Ophthalmic Products are ... formulation of lint-free MEROCEL polyvinyl ... configured to be beneficial to ... being absorbent, and yet firm ...
... Ophthalmic Products are constructed of ... lint-free MEROCEL polyvinyl acetal sponge. ... be beneficial to both surgeon ... and yet firm enough to ...
Medicine Products: